Patient
SITE015-0087
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE015 (POL) (Dr. Ito)
consented 2025-12-10
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
mild
assessed
2026-08-08
Grade 1 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-02-01 (study day 230); relationship: RELATED
mild
assessed
2026-05-18
Grade 1 Peripheral neuropathy — outcome: RECOVERED/RESOLVED; onset 2022-11-11 (study day 148); relationship: NOT RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.